MARKET

HSCS

HSCS

HeartSciences Inc
NASDAQ
3.240
-0.060
-1.82%
Opening 11:09 10/13 EDT
OPEN
3.360
PREV CLOSE
3.300
HIGH
3.420
LOW
3.130
VOLUME
46.76K
TURNOVER
--
52 WEEK HIGH
5.25
52 WEEK LOW
1.630
MARKET CAP
15.69M
P/E (TTM)
-1.0082
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HSCS last week (1005-1009)?
Weekly Report · 1d ago
HeartSciences Secures FDA Clearance for MyoVista wavECG
TipRanks · 6d ago
FDA Grants 510(k) Clearance For HeartSciences’ MyoVista wavECGTM Device As 12-Lead Resting Electrocardiograph
Benzinga · 10/06 14:50
HeartSciences Wins FDA Clearance For MyoVista WavECG; Fortitude Lines Up $100 Mln Miner Deal
NASDAQ · 10/06 13:29
HeartSciences' MyoVista WavECG Device Gets FDA 510(k) Clearance
NASDAQ · 10/06 12:57
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 10/06 12:05
Why Option Care Health Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/06 08:29
Fortitude Secures Priority Supply Allocation for BITMAIN’s Next-Generation Zcash Mining Equipment, Announces $100 Million Non-Binding Purchase Commitment, and Additional Upsizing of DCG Credit Facility and Available ZEC Funding from DCG
Barchart · 10/05 17:10
More
About HSCS
HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.

Webull offers HeartSciences Inc stock information, including NASDAQ: HSCS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HSCS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HSCS stock methods without spending real money on the virtual paper trading platform.